folligen has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajor, T; Balogh, A; Bökönyi, G; Horváth, A; Horváth, J; Kéri, G; Mezö, I; Teplán, I; Vadász, Z; Vántus, T | 1 |
| Balogh, A; Csuka, O; Kéri, G; Szöke, B; Teplán, I | 1 |
2 other study(ies) available for folligen and Breast Cancer
| Article | Year |
|---|---|
Novel antitumor peptide hormones and their effect on signal transduction.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Molecular Sequence Data; Peptides; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Signal Transduction; Somatostatin; Tumor Cells, Cultured | 1992 |
Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line.
Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Gonadotropin-Releasing Hormone; Humans; Phospholipids; Protein Kinase C; Protein-Tyrosine Kinases; Signal Transduction; Thymidine; Tritium; Tumor Cells, Cultured | 1991 |